GENETIC MEDICINES AND INDIVIDUALIZED MANUFACTURING FOR EVERYONE (GIVE)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Contract Value
Not provided
Codes & Classification
Solicitation Number
ARPA-H-SOL-25-129
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AN13
Additional Details
Documents2
The Advanced Research Projects Agency for Health (ARPA-H) has issued a solicitation titled "Genetic Medicines and Individualized Manufacturing for Everyone (GIVE)" under procurement identifier ARPA-H-SOL-25-129. This opportunity is designed to catalyze transformative advancements in the field of genetic medicines, with a particular emphasis on accelerating innovation in the manufacture, testing, and release of RNA-containing modalities.
The GIVE program seeks to address critical challenges in biomanufacturing by fostering equipment and process innovation, driving digital transformation, and promoting the development and commercial adoption of next-generation therapies. The overarching goal is to reimagine the future of biomanufacturing—making it localized, accessible, and tailored to individual needs. Key objectives include harnessing human-machine collaboration, eliminating scale-up costs, and enabling individualized manufacturing approaches that can be deployed broadly.
Contractors responding to this solicitation are expected to propose innovative solutions that advance the state of the art in biomanufacturing, particularly as it relates to RNA-based therapies. Deliverables may encompass novel equipment designs, process improvements, digital tools, or integrated systems that facilitate rapid, flexible, and cost-effective production and testing. The program encourages approaches that support the localization and personalization of manufacturing, with the intent to make advanced genetic medicines more widely available.
The procurement is classified under NAICS code 541714, "Research and Development in Biotechnology (except Nanobiotechnology)," and product service code AN13. There are no set-aside requirements for this solicitation, making it open to all qualified entities. The place of performance is Washington, District of Columbia (DC), United States.
ARPA-H, a federal office, is the contracting entity overseeing this initiative. Interested parties are directed to review the GIVE Innovative Solutions Opening (ISO) and any amendments posted to SAM.gov, including the most recent Amendment 01. Solution summaries are a prerequisite for proposal submission and must be submitted by December 19, 2025, at 5:00 PM ET via the designated submission site: https://solutions.arpa-h.gov/Submit-Solution/. The final response date for the solicitation is February 27, 2026.
Potential contractors should monitor the opportunity for updates and consult the program page at https://arpa-h.gov/explore-funding/programs/give for additional context. While the primary contact information is not directly provided, further details may be available within the solicitation documents or through the official SAM.gov listing.
This solicitation represents a significant opportunity for organizations with expertise in biotechnology R&D, biomanufacturing, and digital health innovation to contribute to a program with the potential to reshape the landscape of genetic medicine production and delivery. The focus on individualized, accessible, and scalable solutions will remain central throughout the contract lifecycle.